Multifrequency tympanometry (MFT) is the measurement of the impedance of the middle ear transmission system at a wide range of frequencies from 200 Hz to 2 kHz. A potential use of MFT as a new diagnostic tool for detecting endolymphatic hydrops has recently been reported. However, its clinical usefulness for diagnosing Ménière’s disease (MD) remains unclear. To evaluate the clinical usefulness of MFT as a new qualitative and diagnostic test for MD, we performed MFT in 70 patients with unilateral or bilateral MD and in 29 normal control subjects. The width of double peaks in the admittance tympanograms (Y width) at 2 kHz and the resonance frequency (RF) were analyzed, and receiver operating characteristic (ROC) curves were constructed. The Y width in MD-affected ears was significantly greater than that in control ears (p < 0.001). The RF in MD-affected ears was significantly lower than that in control ears (p < 0.01). Neither the Y width nor RF had a significant relationship with hearing levels or the results of caloric and vestibular myogenic potential testings. The area under the ROC curve was 0.71 for the Y width and 0.66 for the RF. At the optimal cutoff points, the sensitivity and specificity of the Y width were 47.3 and 86.8%, respectively, and those of the RF were 41.3 and 84.2%, respectively. These results indicated that MFT is significantly associated with the presence of MD, but its diagnostic accuracy is only modest. MFT is a simple, noninvasive test, which should be considered as a complementary test in the diagnosis of MD.

Keywords:
Ménière’s disease, Multifrequency tympanometry, Endolymphatic hydrops, Vestibular evoked myogenic potential, Caloric test
1.
Albers FW, van Weissenbruch R, Casselman JW: 3DFT-magnetic resonance imaging of the inner ear in Meniere’s disease. Acta Otolaryngol 1994;114:595–600.
2.
Anatoli-Candela F: The histopathology of Meniere’s disease. Acta Otolaryngol Suppl (Stockh) 1976;340:5–42.
3.
Bianchedi M, Croce A, Neri G, Moretti A: Multifrequency tympanometry in Meniere’s disease: preliminary results. Acta Otorhinolaryngol Ital 1996;16:1–5.
4.
Bilgen C, Kirkim G, Kirazli T: Middle ear impedance measurements in large vestibular aqueduct syndrome. Auris Nasus Larynx 2009;36:263–268.
5.
Chung WH, Cho DY, Choi JY, Hong SH: Clinical usefulness of extratympanic electrocochleography in the diagnosis of Meniere’s disease. Otol Neurotol 2004;25:144–149.
6.
Colebatch JG, Halmagyi GM: Vestibular evoked potentials in human neck muscles before and after unilateral vestibular deafferentation. Neurology 1992;42:1635–1636.
7.
Colleti V: Tympanometry from 200 to 2000 Hz probe tone. Audiology 1976;15:106–119.
8.
Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–185.
9.
Creten WL, Vanpeperstraete PM, van Camp KJ: Impedance and admittance tympanometry. Audiology 1978;17:97–107.
10.
Darrouzet V, Dulon D, Franco-Vidal V: Multifrequency immittancemetry in experimentally induced stapes, round window and cochlear lesions. Audiol Neurootol 2007;12:85–100.
11.
Fluss R, Faraggi D, Reiser B: Estimation of the Youden index and its associated cutoff point. Biometric J 2005;47:458–472.
12.
Franco-Vidal V, Legarlantezec C, Blanchet H, Convert C, Torti F, Darrouzet V: Multifrequency admittancemetry in Ménière’s disease: a preliminary study for a new diagnostic test. Otol Neurotol 2005;26:723–727.
13.
Friedrichs I, Thornton AR: Endolymphatic hydrops in asymptomatic ears in unilateral Meniere’s disease. Laryngoscope 2001;111:857–860.
14.
Fujimoto C, Murofushi T, Chihara Y, Ushio M, Sugasawa K, Yamaguchi T, Yamasoba T, Iwasaki S: Assessment of diagnostic accuracy of foam posturography for peripheral vestibular disorders: analysis of parameters related to visual and somatosensory dependence. Clin Neurophysiol 2009;120:1408–1414.
15.
Fukuoka H, Tsukada K, Miyagawa M, Oguchi T, Takumi Y, Sugiura M, Ueda H, Kadoya M, Usami S: Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere’s disease. Acta Otolaryngol 2010;130:10–16.
16.
Funasaka S, Kumakawa K: Tympanometry using a sweep-frequency probe tone and its clinical evaluation. Audiology 1988;27:99–108.
17.
Gersdorff M: Clinical value of multifrequential tympanometry. Acta Otorhinolaryngol Belg 1980;34:270–278.
18.
Green JD Jr, Blum DJ, Harner SG: Longitudinal followup of patients with Menière’s disease. Otolaryngol Head Neck Surg 1991;104:783–788.
19.
Hallpike CS, Cairns H: Observations on the pathology of Meniere’s syndrome. Proc R Soc Med 1938;31:1317–1336.
20.
Holte L: Aging effects in multifrequency tympanometry. Ear Hear 1996;7:12–18.
21.
Iseli C, Gibson W: A comparison of three methods of using transtympanic electrocochleography for the diagnosis of Meniere’s disease: click summating potential measurements, tone burst summating potential amplitude measurements, and biasing of the summating potential using a low frequency tone. Acta Otolaryngol 2010;130:95–101.
22.
Lilly DJ: Multiple frequency, multiple component tympanometry: new approaches to an old diagnostic problem. Ear Hear 1984;5:300–308.
23.
Lin MY, Timmer FC, Oriel BS, Zhou G, Guinan JJ, Kujawa SG, Herrmann BS, Merchant SN, Rauch SD: Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops. Laryngoscope 2006;116:987–992.
24.
Mateijsen DJ, Rosingh HJ, Wit HP, Albers FW: Perilymphatic pressure measurement in patients with Menière’s disease. Eur Arch Otorhinolaryngol 2001;258:1–4.
25.
Mom T, Gilain L, Avan P: Effects of glycerol intake and body tilt on otoacoustic emissions reflect labyrinthine pressure changes in Menière’s disease. Hear Res 2009;250:38–45.
26.
Morrison AW, Moffat DA, O’Connor AF: Clinical usefulness of electrocochleography in Meniere’s disease: an analysis of dehydrating agents. Otolaryngol Clin North Am 1980;13:703–721.
27.
Murofushi T, Matsuzaki M, Mizuno M: Vestibular evoked myogenic potential in patients with vestibular schwannomas. Arch Otolaryngol Head Neck Surg 1998;124:509–512.
28.
Murofushi T, Matsuzaki M, Wu CH: Short tone burst-evoked myogenic potentials on the sternocleidomastoid muscle: are these potentials also of vestibular origin? Arch Otolaryngol Head Neck Surg 1999;125:660–664.
29.
Nguyen LT, Harris JP, Nguyen QT: Clinical utility of electrocochleography in the diagnosis and management of Ménière’s disease: AOS and ANS membership survey data. Otol Neurotol 2010;31:455–459.
30.
Ogut F, Serbetcioglu B, Kirazli T, Kirkim G, Code S: Results of multiple-frequency tympanometry measures in normal and otosclerotic middle ears. Int J Audiol 2008;47:615–620.
31.
Paparella MM: The cause (multifactorial inheritance) and pathogenesis (endolymphatic mal absorption) of Meniere’s disease and its symptoms (mechanical and chemical). Acta Otolaryngol (Stockh) 1985;99:445–451.
32.
Rauch SD, Merchant SN, Thedinger BA: Meniere’s syndrome and endolymphatic hydrops. Double-blind temporal bone study. Ann Otol Rhinol Laryngol 1989;98:873–883.
33.
Rauch SD, San Martin J, Moscicki RA, Bloch KJ: Serum antibodies against heat shock protein 70 in Meniere’s disease. Am J Otol 1995;16:648–652.
34.
Sass K: Sensitivity and specificity of transtympanic electrocochleography in Meniere’s disease. Acta Otolaryngol 1998;118:150–156.
35.
Schuknecht HF, Igarashi M: Pathophysiology of Meniere’s disease; in Pfaltz CR (ed): Controversial Aspects of Meniere’s Disease. New York, Georg Thieme, 1986, pp 46–54.
36.
Schmal F, Lubben B, Weiberg K, Stoll W: The minimal ice water caloric test compared with established vestibular caloric test procedures. J Vestib Res 2005;15:215–224.
37.
Shahnaz N, Davies D: Standard and multifrequency tympanometric norms for Caucasian and Chinese young audults. Ear Hear 2006;27:75–90.
38.
Shahnaz N, Polka L: Standard and multifrequency tympanometry in normal and otosclerotic ears. Ear Hear 1997;18:326–341.
39.
Shahnaz N, Polka L: Distinguishing healthy from otosclerotic ears: effect of probe-tone frequency on static immittance. J Am Acad Audiol 2002;13:345–355.
40.
Takeda T, Kakigi A: The clinical value of extratympanic electrocochleography in the diagnosis of Meniere’s disease. ORL J Otorhinolarynogol Relat Spec 2010;72:196–204.
41.
Thomas K, Harrison MS: Long-term follow-up of 610 cases of Ménière’s disease. Proc R Soc Med 1971;64:853–857.
42.
Valvassori GE, Dobben GD: Multidirectional and computerized tomography of the vestibular aqueduct in Meniere’s disease. Ann Otol Rhinol Laryngol 1984;93:547–550.
43.
van Camp KJ, Vanhuyse VJ, Creten WL, Vanpeperstraete PM: Impedance and admittance tympanometry. II. Mathematical approach. Audiology 1978;17:108–119.
44.
Vanhuyse VJ, Creten WL, van Camp KJ: On the W-notching of tympanograms. Scand Audiol 1975;4:45–50.
45.
Welgampola MS, Colebatch JG: Characteristics and clinical application of vestibular-evoked myogenic potentials. Neurology 2005;64:1682–1688.
46.
Yamakawa K: Über die pathologische Veränderung bei einem Meniere-Kranken. J Otolaryngol Jpn 1938;44:2310–2312.
47.
Yasui T, Iwasaki S, Sugasawa M, Sakamoto T, Kashio A, Suzuki M, Kakigi A, Yamasoba T: Admittance tympanometry with 2-kHz probe tones in patients with low-frequency hearing loss. Laryngoscope 2012;122:2252–2255.
48.
Youden WJ: Index for rating diagnostic tests. Cancer 1950;3:32–35.
49.
Zhao F, Wada H, Koike T, Ohyama K, Kawase T, Stephens D: Middle ear dynamic characteristics in patients with otosclerosis. Ear Hear 2002;23:150–158.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.